UK Markets close in 4 hrs 45 mins

Valneva SE (0OB3.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
6.58+0.35 (+5.69%)
As of 11:25AM GMT. Market open.
Full screen
Loading interactive chart…
  • Globe Newswire

    Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate

    Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination scheduleHigher antibody levels were observed in the three-dose vaccination schedule versus the two-dose vaccination schedule, further validating the use of this schedule in the ongoing Phase 3 studyThere were no safety concerns observed in this six-month observational follow up New York & Saint-Herblain (France), December 1, 2022 – Pfizer Inc. (NYSE: PFE) and Va

  • Globe Newswire

    Valneva to Host Investor Day in New York City

    Live event and webcast December 6, 2022 10 AM – 12 PM ET Saint-Herblain (France), November 29, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced it will host an in-person investor day in New York City to discuss the Company’s current vaccine pipeline, commercial products, and future directions from 10:00 AM to 12:00 PM ET on Tuesday, December 6, 2022. The event will also be webcast live and archived on the Company’s website. Valneva’s Chief Execu

  • Globe Newswire

    Valneva Appoints Dipal Patel as Chief Commercial Officer

    Saint-Herblain (France), November 17, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dipal Patel as Chief Commercial Officer (CCO) and Management Board member. With this newly created role, Valneva strengthens its management team with a recognized commercial industry leader as the Company advances its chikungunya vaccine candidate towards potential market entry in 2023. Ms. Patel is an established commercial leader with over